Drugs / Natural killer cell

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT03358849 Oct 2017 → Sep 2018 biliary tract cancer Yonsei University Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT02844335 Jul 2016 → Jul 2017 female breast carcinoma Fuda Cancer Hospital, Guangzhou Completed No outcome recorded
Phase 1/2 NCT02843802 Jul 2016 → Jul 2017 secondary malignant neoplasm Fuda Cancer Hospital, Guangzhou Completed No outcome recorded
Phase 1/2 NCT02849015 Jul 2016 → Jul 2017 liver cancer Fuda Cancer Hospital, Guangzhou Completed No outcome recorded
Phase 1/2 NCT02843815 Jul 2016 → Jul 2017 non-small cell lung carcinoma Fuda Cancer Hospital, Guangzhou Completed No outcome recorded
Phase 21 trial
Phase 2 NCT05754684 Jan 2022 → Dec 2025 overdue neuroblastoma Hong Kong Children's Hospital Recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Natural killer cell Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02844335
5

Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02843802

Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02843815

Natural killer cell(each treatment: about 10 billion cells transfusion in 3 times, i.v.)” NCT02849015

NCT05754684

NCT03358849

Action Deplete “it is a cytotoxic cell that can immediately remove cancer cells without any other activation process” NCT03358849
Modality Cell therapy “Natural killer cell” NCT02843802
Route Intravenous “i.v.” NCT02843802